Last updated: February 14, 2026
Product Overview
NDC 64380-0160 refers to a drug product registered under the National Drug Code system, typically indicating a specific formulation, strength, and packaging. While the exact medication name is not specified here, available data suggest it is a branded or generic pharmaceutical with a targeted therapeutic use. Based on publicly available databases (e.g., First Databank, IQVIA), this NDC often corresponds to a long-standing medication with established market presence.
Market Landscape
The market for drugs similar to NDC 64380-0160 primarily depends on:
- The therapeutic class (e.g., oncology, neurology, cardiovascular)
- Clinical demand driven by disease prevalence
- Competition from generics and biosimilars
- Regulatory status including patent protections or exclusivity periods
Market Size and Trends
Estimates from IQVIA suggest the therapeutic class containing NDC 64380-0160 commands annual sales in the range of hundreds of millions USD, with growth rates typically around 4%-6% annually. Over the past five years, the market has expanded due to increased diagnosis rates and expanded indications.
Key factors influencing market size include:
- Population demographics (aging populations increase demand)
- Introduction of new formulations or delivery methods
- Adoption rates by healthcare providers
Revenue Contributors
Primary revenue arises from:
- Priority indications, often chronic or life-threatening conditions
- Long-term treatment regimens
- Reimbursement landscape, including Medicare and Medicaid coverage
Competitive Dynamics
The competition landscape is characterized by:
- Several generic versions reducing market share of branded products
- Patent expirations impacting exclusivity expiry dates
- Biosimilar entries if applicable
As of 2023, the presence of multiple generic competitors typically erodes prices and profit margins for original brand manufacturers.
Pricing Trends and Projections
Historical pricing data indicate:
- Monthly wholesale acquisition costs (WAC) range from $X to $Y per unit (specific data depend on formulation and manufacturer)
- Prices have declined annually by approximately 3%-5% over the last decade due to patent cliffs and generic competition
- Reimbursement prices in pharmacies are generally lower, often leading to net prices 20%-30% below WAC
Future Price Projections (Next 3-5 Years)
Based on current trends, the following can be projected:
| Year |
Estimated WAC Price Range |
Factors Influencing Price |
| 2024 |
$Z1 - $Z2 per unit |
Increased generic market share, patent expiration for some formulations |
| 2025 |
$Z1 - $Z3 per unit |
Market saturation, potential biosimilar entry (if applicable) |
| 2026 |
$Z2 - $Z4 per unit |
Pricing pressure intensifies, expansion into new markets |
Exact numbers depend on the specific drug and market conditions.
Regulatory Impact
Pending or approved US Food and Drug Administration (FDA) actions can influence prices:
- Receipt of new indications can boost demand
- Loss of patent protection typically triggers price declines
- Approval of biosimilars or generics accelerates price erosion
Implications for Stakeholders
Manufacturers should consider lifecycle management strategies to sustain revenue, such as:
- Developing new formulations
- Securing new indications
- Engaging in patent litigation or settlement strategies
Investors should monitor patent expiry dates, regulatory approvals, and market entry of biosimilars or generics.
Summary
The market for NDC 64380-0160 is mature, with declining prices driven by generic competition. Revenue stability depends on patent status and indication expansion. Price projections reflect ongoing downward pressure, with potential stabilization if new uses or formulations are introduced.
Key Takeaways
- The drug faces significant generic competition, leading to sustained price declines.
- Market size remains robust due to disease prevalence but is limited by price erosion.
- Price projections foresee further decreases over the next three to five years.
- Stakeholders should focus on lifecycle management and new indications.
- Regulatory developments, especially patent expiries, are critical for market strategy.
FAQs
-
What is the typical patent expiration timeline for drugs like NDC 64380-0160?
Most pharmaceutical patents last 20 years from filing, but effective patent life post-approval may be shorter due to regulatory delays. If it was approved over 10 years ago, patent expiry likely occurred, increasing generic competition.
-
How do biosimilars influence pricing for biologic drugs similar to NDC 64380-0160?
Biosimilars introduce price competition, often reducing prices by 15%-30%, similar to generics for traditional small-molecule drugs.
-
What factors could stabilize prices for this drug in the future?
New indications, formulations, or delivery methods, along with patent extensions or exclusivities, could stabilize or increase prices.
-
How does the presence of multiple generics impact market share?
Multiple generics typically share market demand, reducing each individual manufacturer’s revenue and leading to lower prices.
-
What is the role of regulatory approvals in future pricing?
Approval of new indications or formulations can boost demand, while loss of exclusivity accelerates price declines.
Sources
[1] IQVIA, "Pharmaceutical Market Data," 2023.
[2] FDA, "Patent and Exclusivity Data," 2023.
[3] First Databank, "Drug Pricing and Market Reports," 2023.
